Virtual Medicinal Product (VMP) - Co-prenozide 160mg/0.25mg modified-release tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Co-prenozide 160mg/0.25mg modified-release tablets Start Date 04-05-2004 End Date
Previous Name Previous Name Co-prenozide 160/0.25 modified-release tablets Start Date 23-12-2002 End Date 03-05-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Modified-release tablet
Ontology Form/Route
tabletmodified-release.oral
Non-availability Indicator
Actual Products not Available
Name Basis
BAN - British Approved Name

Codes

ATC Code
C07BA02
BNF Start Date End Date
Current BNF 02040000 Start Date 04-04-2022 End Date
Previous BNF 02040000 Start Date 03-02-2005 End Date 29-11-2012
SNOMED Codes
Code Start Date End Date
36091611000001101 31-10-2018
318583001 23-12-2002 30-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cyclopenthiazide Based on Ingredient Substance 250 microgram
Oxprenolol hydrochloride Based on Ingredient Substance 160 mg

Parent Products

  • VTM
    Co-prenozide
    • VMP
      (Current) Co-prenozide 160mg/0.25mg modified-r...
      • AMP

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet